SWHR, ACOG, and WFRC called for sustained funding after a new women’s health executive order.
|Articles|October 7, 2020
HHS announces provider relief funding of $20 billion
Author(s)Lindsey Carr, Editor
Application for the funds began on Oct. 5.
Advertisement
The U.S. Department of Health and Human Services (HHS) announced $20 billion in new funding through the Health Resources and Services Administration (HRSA). The funds are intended to help providers on the frontlines of the COVID-19 pandemic.
The application process began on Oct. 5 and will end on Nov. 6. This general Phase 3 general distribution will allow providers who have already received Provider Relief Fund payments to apply, as well as those previously ineligible.
For more information on eligibility and application processes, visit
Advertisement
Related to this article
Real-world fezolinetant (Veozah) sleep data help ob-gyns counsel patients hesitant about hormone therapy, according to Marla Shapiro, CM, MDCM.
Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
In September, the FDA accepted an extended duration sNDA for the IUD with a decision expected in Q2 2027.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
ACOG issued its most comprehensive menopause guidance, grading treatments for VMS, sleep, and mood symptoms.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG guideline expands menopause VMS, sleep, and mood recommendations
2
Executive order directs NIH to create women's health division
3
Actigraphy and Objective Sleep Outcomes in Menopause VMS Treatment
4
Organon reports interim phase 3 data for MIUDELLA IUD through 6 years
5